IVIG Courses (Mean/Range, in Months) | Response to IVIG (N - %) | Therapy Concurrent with IVIG | Additional Therapy if NR/PR | Relapse Among SR | IVIG Treatment of Relapse in SR | Clinical Course After IVIG Treatment of Relapse | Progression to CDM |
---|---|---|---|---|---|---|---|
All: 4.8 (1-15) SR: 5.3 (3-15) |
NR: 4(15%) PR: 4(15%) SR: 19(70%) |
All: 17(63%) TAC: 2(7%) CLQ: 1(4%) HCQ: 9(33%) SGC: 6(22%) |
SGC: 7(26%) MTX: 1(4%) MMF: 1(4%) HCQ: 2(7%) |
10 (53%) | 6 (60%) | Required Multiple courses of IVIG: 3/6 Treatment following IVIG Retreatment SGC=2, MTX=2 TGC=2 |
6/27 (22%) 0/9 non-relapsed SR 2/10 relapsed SR 4/8 NR or PR |